Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein

Carcinogenesis

Volumn 31, Issue 5, 2010, Pages 918-926

  Laurson, Joanna ^a   Khan, Sadaf ^a   Chung, Rachel ^a   Cross, Karen ^a   Raj, Kenneth ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; PROTEIN E7; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2 ALPHA; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPIGENETICS; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; LANGERHANS CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; DRUG ANTAGONISM; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY;

CADHERINS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; HUMANS; PAPILLOMAVIRUS E7 PROTEINS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR AP-2;

EID: 77952312249     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq027     Document Type: Article

References (79)

1. Howley, P.M. (1987) The role of papillomaviruses in human cancer. Important Adv. Oncol., 55-73.
2. zur Hausen, H. et al. (1984) Viruses in the etiology of human genital cancer. Prog. Med. Virol., 30, 170-186.
3. Huibregtse, J.M. et al. (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J., 10, 4129-4135.
4. Huibregtse, J.M. et al. (1994) E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. Cold Spring Harb. Symp. Quant. Biol., 59, 237-245.
5. Scheffner, M. et al. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
6. Scheffner, M. et al. (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl Acad. Sci. USA, 88, 5523-5527.
7. Scheffner, M. et al. (1992) Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins. EMBO J., 11, 2425-2431.
8. Brown, D.R. et al. (2005) A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J. Infect. Dis., 191, 182-192.
9. Dalstein, V. et al. (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int. J. Cancer, 106, 396-403.
10. Rodriguez, A.C. et al. (2008) Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J. Natl Cancer Inst., 100, 513-517.
11. Plummer, M. et al. (2007) A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis., 195, 1582-1589.
12. Giannini, S.L. et al. (2002) Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int. J. Cancer, 97, 654-659.
13. Petry, K.U. et al. (1994) Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int. J. Cancer, 57, 836-840.
14. Tindle, R.W. (2002) Immune evasion in human papillomavirus-associated cervical cancer. Nat. Rev. Cancer, 2, 59-65.
15. Romani, N. et al. (1989) Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med., 169, 1169-1178.
16. al-Saleh, W. et al. (1995) Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch., 427, 41-48.
17. Connor, J.P. et al. (1999) Evaluation of Langerhans' cells in the cervical epithelium of women with cervical intraepithelial neoplasia. Gynecol. Oncol., 75, 130-135.
18. Fukuda, K. et al. (1993) Local immune response in persistent cervical dysplasia. Obstet. Gynecol., 82, 941-945.
19. Guess, J.C. et al. (2005) Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J. Virol., 79, 14852-14862.
20. Hawthorn, R.J. et al. (1988) Langerhans' cells and subtypes of human papillomavirus in cervical intraepithelial neoplasia. Br. Med. J., 297, 643-646.
21. Hubert, P. et al. (2005) E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J. Pathol., 206, 346-355.
22. Hughes, R.G. et al. (1988) Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia. J. Clin. Pathol., 41, 253-259.
23. McArdle, J.P. et al. (1986) Quantitative assessment of Langerhans' cells in human cervical intraepithelial neoplasia and wart virus infection. Am. J. Obstet. Gynecol., 154, 509-515.
24. Morelli, A.E. et al. (1993) Relationship between types of human papillomavirus and Langerhans' cells in cervical condyloma and intraepithelial neoplasia. Am. J. Clin. Pathol., 99, 200-206.
25. Morris, H.H. et al. (1983) Langerhans' cells in human cervical epithelium: an immunohistological study. Br. J. Obstet. Gynaecol., 90, 400-411.
26. Tay, S.K. et al. (1989) Langerhans cell population in early invasive squamous cell carcinoma of the uterine cervix. Aust. N. Z. J. Obstet. Gynaecol., 29, 38-40.
27. Viac, J. et al. (1990) Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: correlation with human papillomavirus infection. Immunobiology, 180, 328-338.
28. Bhushan, M. et al. (2002) Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br. J. Dermatol., 146, 32-40.
29. Jakob, T. et al. (1998) Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J. Immunol., 160, 4067-4073.
30. Rupec, R. et al. (1996) Granulocyte/macrophage-colony-stimulating factor induces the migration of human epidermal Langerhans cells in vitro. Exp. Dermatol., 5, 115-119.
31. Hubert, P. et al. (1999) Colonization of in vitro-formed cervical human papillomavirus-associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. Am. J. Pathol., 154, 775-784.
32. Halliday, G.M. et al. (2001) Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int. Immunol., 13, 1147-1154.
33. Charbonnier, A.S. et al. (1999) Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J. Exp. Med., 190, 1755-1768.
34. Caberg, J.H. et al. (2009) Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol. Immunother., 58, 39-47.
35. Wang, B. et al. (1999) Role of cytokines in epidermal Langerhans cell migration. J. Leukoc. Biol., 66, 33-39.
36. Mota, F. et al. (1999) The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin. Exp. Immunol., 116, 33-40.
37. Tang, A. et al. (1993) Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature, 361, 82-85.
38. Udey, M.C. (1997) Cadherins and Langerhans cell immunobiology. Clin. Exp. Immunol., 107 (suppl. 1), 6-8.
39. Denk, C. et al. (1997) Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines. Cancer Lett., 120, 185-193.
40. Chen, C.L. et al. (2003) E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours. Eur. J. Cancer, 39, 517-523.
41. Matthews, K. et al. (2003) Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J. Virol., 77, 8378-8385.
42. Fujimoto, J. et al. (1997) Expression of E-cadherin and alpha-and beta-catenin mRNAs in uterine cervical cancers. Tumour Biol., 18, 206-212.
43. de Boer, C.J. et al. (1999) Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am. J. Pathol., 155, 505-515.
44. Van de Putte, G. et al. (2004) E-cadherin and catenins in early squamous cervical carcinoma. Gynecol. Oncol., 94, 521-527.
45. Yaldizl, M. et al. (2005) Expression of E-cadherin in squamous cell carcinomas of the cervix with correlations to clinicopathological features. Eur. J. Gynaecol. Oncol., 26, 95-98.
46. Sun, H. et al. (2000) [E-cadherin expression and its clinical significance in cervical cancer]. Zhonghua Zhong Liu Za Zhi, 22, 496-498.
47. Daniel, B. et al. (1997) The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol., 78, (Pt 5)1095-1101.
48. Branca, M. et al. (2006) Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer. Eur. J. Gynaecol. Oncol., 27, 215-223.
49. Kaplanis, K. et al. (2005) E-cadherin expression during progression of squamous intraepithelial lesions in the uterine cervix. Eur. J. Gynaecol. Oncol., 26, 608-610.
50. Faleiro-Rodrigues, C. et al. (2004) E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study. Pathobiology, 71, 329-336.
51. Jeffers, M.D. et al. (1997) E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the cervix. Gynecol. Oncol., 64, 481-486.
52. Rodriguez-Sastre, M.A. et al. (2005) Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol. Oncol., 97, 330-336.
53. Vessey, C.J. et al. (1995) Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J. Pathol., 176, 151-159.
54. Allen-Hoffmann, B.L. et al. (2000) Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J. Invest. Dermatol., 114, 444-455.
55. Hoffmann, R. et al. (2006) Different modes of human papillomavirus DNA replication during maintenance. J. Virol., 80, 4431-4439.
56. Reinhold, W.C. et al. (2007) Detailed methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol. Cancer Therapy, 6, 391-403.
57. Park, R.B. et al. (2002) Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol., 76, 11359-11364.
58. Thomas, J.T. et al. (1999) Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl Acad. Sci. USA, 96, 8449-8454.
59. Demers, G.W. et al. (1994) Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology, 198, 169-174.
60. Caberg, J.H. et al. (2008) Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis, 29, 1441-1447.
61. Jung, J.K. et al. (2007) Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res., 67, 5771-5778.
62. Lee, J.O. et al. (2005) Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene, 24, 6617-6625.
63. Liu, J. et al. (2006) Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene, 25, 1008-1017.
64. Iso, Y. et al. (2005) Loss of E-cadherin mRNA and gain of osteopontin mRNA are useful markers for detecting early recurrence of HCV-related hepatocellular carcinoma. J. Surg. Oncol., 92, 304-311.
65. Arora, P. et al. (2008) Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett., 261, 244-252.
66. Fahraeus, R. et al. (1992) Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int. J. Cancer, 52, 834-838.
67. Krishna, S.M. et al. (2005) Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomark., 1, 271-277.
68. Tsai, C.N. et al. (2002) The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl Acad. Sci. USA, 99, 10084-10089.
69. Tsai, C.L. et al. (2006) Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res., 66, 11668-11676.
70. Hajra, K.M. et al. (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res., 62, 1613-1618.
71. Park, S.H. et al. (2008) Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol. Endocrinol., 22, 2085-2098.
72. Hellner, K. et al. (2009) HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology, 391, 57-63.
73. Beger, M. et al. (2001) Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription. J. Mol. Med., 79, 314-320.
74. Burgers, W.A. et al. (2007) Viral oncoproteins target the DNA methyltransferases. Oncogene, 26, 1650-1655.
75. Leong, K.G. et al. (2007) Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J. Exp. Med., 204, 2935-2948.
76. Herfs, M. et al. (2008) Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. Am. J. Pathol., 172, 1391-1402.
77. Shamay, M. et al. (2006) Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc. Natl Acad. Sci. USA, 103, 14554-14559.
78. Azzimonti, B. et al. (2009) The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. Virology, 388, 260-269.
79. Morris, H.H. et al. (1983) Langerhans' cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasia. Br. J. Obstet. Gynaecol., 90, 412-420.